Furthermore, increased CBX7 greatly reduced tumour proliferation as measured by PCNA (Fig. 6D, E), and one CBX7 target, cyclin E1, which is essential for liver cancer progression [53, 54], was significantly reduced upon increased CBX7 expression (Fig. 6F, G). Here, CCNE1 is linked to liver cancer.